{"id":"W4376226544","doi":"10.1182/bloodadvances.2022007059","title":"CD38 as a pan-hematologic target for chimeric antigen receptor T cells","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institutes of Health; Incyte; Andrew McDonough B+ Foundation; American Society of Clinical Oncology; American Association for Cancer Research; St. Baldrick's Foundation; Stand Up To Cancer; National Cancer Institute; Entertainment Industry Foundation; Gilead Sciences; Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Chimeric antigen receptor; CD38; Cart; Haematopoiesis; Antigen; Cancer research; Medicine; Immunology; Myeloid leukemia; Immunotherapy; T cell; Myeloid; Leukemia; Stem cell; Biology; CD34; Immune system; Cell biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002818934,0.000183546,0.0004172414,0.0001672491,0.0001157542,0.00002248879,0.0001833921,0.00008457815,0.002235037],"category_scores_gemma":[0.0002010772,0.0001478119,0.0001713518,0.0006482435,0.0001027498,0.0001003802,0.00005757973,0.0001539919,0.001015307],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001935264,"about_ca_system_score_gemma":0.0001048446,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001229483,"about_ca_topic_score_gemma":0.000003338953,"domain_scores_codex":[0.9983923,0.00004161825,0.0002451498,0.0004122719,0.0003508039,0.0005578179],"domain_scores_gemma":[0.9990687,0.0002757546,0.00007688648,0.0003351423,0.00009391783,0.0001495518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000434566,0.0003257623,0.005504507,0.0003586927,0.0002015375,0.00008269846,0.0002486542,0.00001205281,0.9530322,0.0001607845,0.009716569,0.02992195],"study_design_scores_gemma":[0.001644486,0.0008906111,0.0005928149,0.00005512454,0.00003827456,0.00003611342,0.0002577374,0.0000508637,0.4784147,0.001204837,0.5166484,0.0001660532],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809532,0.006208419,0.0001019153,0.001622432,0.0005990153,0.001761169,0.00006052617,0.0004989016,0.008194426],"genre_scores_gemma":[0.6930332,0.03283147,0.05104108,0.00173514,0.002632122,0.001731761,0.0006894169,0.000378301,0.2159275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5069318,"threshold_uncertainty_score":0.9997625,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0267371039918525,"score_gpt":0.3417820071623222,"score_spread":0.3150449031704697,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}